High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.
about
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-AnalysisCarbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.A Study of 24 Patients with Colistin-Resistant Gram-negative Isolates in a Tertiary Care Hospital in South India.Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern ChinaPredictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.Resistance to Colistin in Klebsiella Pneumoniae: A 4.0 Strain?European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in LeukemiaPolymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study.Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance.Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan.First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosisSevere community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection.Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014Carbapenemase-producing Enterobacteriaceae.Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy.A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical CharacteristicsCorrelation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae.Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae.Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection.Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.Evolution and Epidemiology of Multidrug-Resistant Klebsiella pneumoniae in the United Kingdom and Ireland.A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence.Current strategies for the treatment of complicated intraabdominal infections.Confronting carbapenemase-producing Klebsiella pneumoniae.Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance.In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.The rapid spread of carbapenem-resistant Enterobacteriaceae.Open Conversion after Aortic Endograft Infection Caused by Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae.
P2860
Q26764796-9DB6A5E6-F167-41D7-9EDA-864DBAE9EABBQ33623060-221328BE-F295-4DFF-9083-7715C9299F2BQ33662378-6A279D72-83CE-49C3-951C-F988AF69C8EFQ33755535-754CA448-723B-4934-9C55-9FE67FAA4CEAQ33790342-B437619A-53ED-43E6-B1B4-D7156852A044Q33798081-1C8C2FAB-FA15-419C-B0F6-D4B65357EE51Q33803459-E0DEF03D-3404-4539-92C1-70741DC8D60CQ34390823-D8B3D510-1403-4757-B407-27BC12935C6FQ34552966-14DEC7B8-1480-49C5-87A4-C588C5BF5E39Q34676586-BCA1F6D3-E336-4B16-B077-F95CA55496B2Q34922881-9354C1CB-DE31-4E40-A077-F77B330F406EQ35079204-3185E93C-2562-4590-B3C4-687723B2D50DQ35193295-FBC471C5-DC05-4A21-93D0-27DFB40336E1Q35236296-DDD556BF-D814-4AC6-867F-91AC79F6C41BQ35297743-65CCF621-B321-4C80-B681-6B78AE958644Q35676151-7A9A9AC9-4663-462B-B65B-B32039440A1EQ35751615-8B29AFF5-8F2C-4F2E-B1BE-3CA3915C769FQ36150730-634A1B8B-7634-4E17-B4EE-FBBD02186C65Q36181417-C3D02E67-6092-4DFC-95DA-56C05DB85A4DQ36304704-23AF2367-CC90-4F13-B52A-C94AC636EC1BQ36438958-9E7D1B3C-813E-49E5-8C79-D057D80663E8Q36644582-1D64DE1B-CEFD-4543-A9D4-6EC19A782DA4Q37188061-C97160B1-574F-4E6B-86B2-BCEC4B679DF8Q37203731-B7676FF0-2DA3-43E9-9925-03A9BB7554CEQ37206036-1FD6156B-61B6-41B2-A71A-A1597784C4F4Q37374197-160F5DD1-9661-4C94-9935-23DDFDF60D22Q37544860-85C39941-6EA7-45A5-A5D5-D11D074DA274Q37712123-988B1ED7-6A51-418D-847B-10EFD1FAA914Q37734003-E4431626-76DC-49D6-ADEC-83DFAD25367CQ38123247-D4C438E4-3216-4F49-974B-83F9B91CE51AQ38135903-A449448E-5D2A-47DB-A06A-3A063BEC4579Q38145311-86F92A29-17DD-4829-B237-2C33A9E3566FQ38147851-E733283C-7B83-4356-BF72-F63182AD60CDQ38262205-6D6718F9-EAC7-40B5-86F3-D6AD711F16B9Q38324448-A704B88C-573B-4287-8694-15825436A73BQ38860187-2722AB2A-2C7B-4AC8-A5DA-8F38DB215E73Q38875315-72118014-D08C-4676-A3C7-342FD794B3F3Q38918458-4BAFF4C6-8003-4D5F-A69F-E6C742722C38Q39027434-663E8087-25DC-4406-B5C3-E8EA2578772CQ39252826-C28723D2-8205-4B57-88B3-3CFE660230B8
P2860
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High rate of colistin resistan ...... ts for an excess of mortality.
@en
High rate of colistin resistan ...... ts for an excess of mortality.
@nl
type
label
High rate of colistin resistan ...... ts for an excess of mortality.
@en
High rate of colistin resistan ...... ts for an excess of mortality.
@nl
prefLabel
High rate of colistin resistan ...... ts for an excess of mortality.
@en
High rate of colistin resistan ...... ts for an excess of mortality.
@nl
P2093
P50
P356
P1476
High rate of colistin resistan ...... ts for an excess of mortality.
@en
P2093
A Giordano
M Ballardini
M Meledandri
M P Balice
P304
P356
10.1111/1469-0691.12070
P577
2012-11-09T00:00:00Z